Skip to main content
. 2022 May 20;13:858207. doi: 10.3389/fphar.2022.858207

FIGURE 1.

FIGURE 1

The one-way sensitivity analyses. Abbreviation: TGP, toripalimab plus gemcitabine and cisplatin; CGP, camrelizumab plus gemcitabine and cisplatin; GP, gemcitabine plus cisplatin; PFS, progression-free survival; BSC, best supportive care.